Cargando…
Acquisition of a Stable and Transferable bla (NDM-5)-Positive Plasmid With Low Fitness Cost Leading to Ceftazidime/Avibactam Resistance in KPC-2-Producing Klebsiella pneumoniae During Treatment
The emergence and prevalence of carbapenem-resistant Enterobacteriaceae (CRE) have drawn worldwide attention. Ceftazidime/avibactam (CAZ/AVI) gives us a valuable alternative strategy to treat CRE infections. Unfortunately, CAZ/AVI resistance could occur during CAZ/AVI treatment. The CAZ/AVI-resistan...
Autores principales: | Huang, Jiangqing, Zhang, Shengcen, Zhao, Zhichang, Chen, Min, Cao, Yingping, Li, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329419/ https://www.ncbi.nlm.nih.gov/pubmed/34354959 http://dx.doi.org/10.3389/fcimb.2021.658070 |
Ejemplares similares
-
Dynamic evolution of ceftazidime–avibactam resistance due to interchanges between bla(KPC-2) and bla(KPC-145) during treatment of Klebsiella pneumoniae infection
por: Chen, Yili, et al.
Publicado: (2023) -
Ceftazidime-Avibactam Resistance in Klebsiella pneumoniae Sequence Type 11 Due to a Mutation in Plasmid-Borne bla(kpc-2) to bla(kpc-33), in Henan, China
por: Li, Debao, et al.
Publicado: (2021) -
In vitro Synergistic Activity of Ceftazidime-Avibactam in Combination with Aztreonam or Meropenem Against Clinical Enterobacterales Producing bla(KPC) or bla(NDM)
por: Kuai, Junyang, et al.
Publicado: (2023) -
Acquisition of resistance to ceftazidime-avibactam during infection treatment in Pseudomonas aeruginosa through D179Y mutation in one of two bla(KPC-2)
gene copies without losing carbapenem resistance
por: García, Patricia, et al.
Publicado: (2022) -
Isolation of a Ceftazidime-Avibactam-Resistant bla(KPC-71)-Positive Klebsiella pneumoniae Clinical Isolate
por: Shen, Siquan, et al.
Publicado: (2022)